Sunday, 20 September 2026European Markets

NORDIC SEMICONDUC Stock Bullish Momentum With A 9.92% Rise On Monday

Loading stream...

(VIANEWS) - The Market ended the session with NORDIC SEMICONDUC (NOD.OL) rising 9.92% to kr85.12 on Monday, after four sequential sessions in a row of losses. Oslo Børs Benchmark Index_GI dropped 0.04% to kr1,350.90, after four sequential sessions in a row of gains, on what was a somewhat down trend exchanging session today.

NORDIC SEMICONDUC's last close was kr77.44, 49.84% below its 52-week high of kr154.40.

About NORDIC SEMICONDUC

Nordic Semiconductor ASA, a fabless semiconductor company, designs, sells, and delivers integrated circuits (ICs) and related products and services for use in short- and long- range wireless applications in Europe, the Americas, and the Asia Pacific. The company offers cellular IoT solutions comprising NB-IoT and LTE-M; Wi-Fi solution; Bluetooth Low Energy Systems-on-Chip (SoCs); Bluetooth LE audio products; Bluetooth mesh; Bluetooth direction finding solution; DECT NR+, a non-cellular radio standard; Thread, an IP-based wireless networking protocol solution; Zigbee products; ANT solutions, including wireless multiprotocol SoCs supporting the ANT wireless protocol; nRF52 and nRF51 wireless SoCs; and range extenders. It also provides Matter, a Connected Home over IP solution; Amazon sidewalk; multiprotocol SoCs; Bluetooth wireless technology; security solution; power management ICs comprising nPM1100 PMIC, nPM1300 PMIC, and nPM6001 PMIC; cloud services, such as location, security, and device management services; nRF Cloud solution; and application specific integrated circuits and related consulting services. The company's products are used in various applications, such as audio, automotive, asset tracking, beacon, computer peripherals, connected health, smart agriculture, smart home and metering, education, building automation, LED lighting, logistics and transport, retail and payment, sports and fitness, toys and gaming, virtual reality and augmented reality products, and wearables. Nordic Semiconductor ASA was founded in 1983 and is headquartered in Trondheim, Norway.

Earnings Per Share

As for profitability, NORDIC SEMICONDUC has a trailing twelve months EPS of kr0.43.

PE Ratio

NORDIC SEMICONDUC has a trailing twelve months price to earnings ratio of 197.95. Meaning, the purchaser of the share is investing kr197.95 for every norwegian krone of annual earnings.

Return on Equity

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 1.29%.

Yearly Top and Bottom Value

NORDIC SEMICONDUC's stock is valued at kr85.12 at 22:30 EST, way below its 52-week high of kr154.40 and way above its 52-week low of kr76.96.

Sales Growth

NORDIC SEMICONDUC's sales growth is negative 46.3% for the ongoing quarter and negative 39.7% for the next.

More news about NORDIC SEMICONDUC (NOD.OL).

In this story · Knowledge Files

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Boom Hits a Fork: Slowdown Calls Clash with Capex Confidence as Markets Get Nervous
Dario Amodei's repeated calls for a global slowdown in frontier AI development, echoed by Microsoft's new humanist AI code of conduct and FTC antitrust caution, are being publicly rejected by Nvidia and Meta leadership even as hyperscaler spending draws fresh skeptical scrutiny (Wachter's analysis, Burry-style overbuilding worries) and weak guidance from Adobe and a post-slowdown-comment selloff in GE Vernova signal investor jitters. Meanwhile wealth and security effects of the AI race keep compounding — Zhang Yiming's fortune surging on AI-driven ByteDance value, a Chinese hacking firm weaponizing AI against stolen government secrets, and low-quality AI-generated products (an AI sitcom, a spam-flooding agent platform) fueling backlash even as adoption races ahead.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Berkshire Hathaway
Both facts report Berkshire Hathaway's cash position on 2026-01-01 with identical observation timestamps, but claim vastly different values: 380 billion USD vs 400 USD. These cannot both be true for the same entity at the same point in time. The magnitude of the discrepancy (a factor of ~10^9) rules out rounding, unit conversion, or methodological differences.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,982
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,982 facts checked against source5,299 source documents archived
Query this data → isubstrate.com